جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

14 مُخرَج نتائج البحث عن «Microbiome»

نسخة أوليةمفتوح (مستودع)2026

A Pilot Study on the Urinary Microbiome Composition and Diversity in Clinical UTI Samples: A 16S rRNA Analysis

bioRxiv (Cold Spring Harbor Laboratory)

Abstract This pilot study assessed the composition and diversity of the urinary microbiome from clinically confirmed UTI samples using 16S rRNA sequencing, whilst also exploring inter-individual variability of microbial community structure. We examined ten urine samples from patients with culture-positive UTIs. Demographic and clinical metadata, including age, sex, body mass index (BMI), diabetes status and recent antibiotic exposure was recorded per sample. Metagenomic DNA was extracted from microbial samples and sequenced to generate genus-level taxonomic profiling through 16S rRNA gene sequencing. Relative abundance tables were generated for each of the samples to identify dominant bacterial genera within each sample and summarize cohort level microbial patterns. To evaluate within-sample richness and evenness, alpha diversity indices (Shannon, Simpson, observed features and Chao1) were computed; beta diversity was measured using Bray–Curtis dissimilarity with principal coordinates analysis (PCoA) for graphical representation. The study’s findings revealed the sex and moderate clinical diversity of the study sample; all samples were confirmed as having been taken from a UTI patient and exhibited a wide level of heterogeneity regarding the microbial composition of each urine sample. Overall, Pseudomonas was the dominant genus present, however, specific samples had approximately 50% of their microbiomes composed of Klebsiella, Proteus, and Escherichia species as well as approximately 25% of their total microbes were made up of Burkholderia spp., which are closely related to the genus of interest used during the course of this study. The observed alpha diversity of each sample displayed considerable variation for the included samples with a continuum of samples ranging from a single dominant microbe to a highly diverse mixed population producing a highly diverse polymicrobial population/bacterial composition, with some ratios of individual taxa to collective taxa of many samples repeatedly illustrating the exact nature of the specimen. Furthermore, a significant degree of Beta diversity was found between the patients, providing compelling evidence of identifiable differences among urinary microbiomes between patients with UTI. This pilot project provides a clear indication of the diversity and overall heterogeneity of urinary microbiota found in the UTI patients studied. In addition, the results of this study support the notion that the ecological complexities present within a urinary microbiome cannot necessarily be established through conventional culture methods, and that combined with molecular techniques such as 16S rRNA sequencing of bacterial DNA could be used to quantify and characterize the ecologic condition of urinary microbiota separate from the traditional high prevalence of identifiable uropathogens.

urinary microbiomeurinary tract infectionbacterial diversityPseudomonas
مراجعةوصول مفتوح202511استشهاد· Semantic Scholar

The role of probiotics in promoting systemic immune tolerance in systemic lupus erythematosus

Gut Pathogens · مجلد 17 (1) · 45-45

Systemic lupus erythematosus (SLE) is an autoimmune disorder branded via over-activation of the immune system, resulting in atypical roles of natural and adaptive immune cells and the making of numerous autoantibodies against nuclear components. The causes and pathogenesis of this disease are not completely realized. The gut microbiota plays a significant character in human health and disorder, particularly in autoimmune diseases.Gut microbiome dysbiosis can affect the host immune system as suggested by several recent studies, balance and activity of the gut microbiome, which are influenced by daily diet, might be associated with disease activity in SLE. There are rising signs to support the immunomodulatory abilities of certain probiotics. Numerous investigational and clinical surveys have demonstrated the useful effects of certain probiotic bacteria, mainly strains of Lactobacillus and Bifidobacterium, in patients with SLE. Various species of bacteria were found to be positively or negatively associated with SLE gut microbiomes. A better comprehension of the Studying the gut microbiota will provide a good opportunity to identify microbes involved in tolerance in systemic lupus patients. The purpose of this study is to review the existing literature on probiotics that have the ability to restore tolerance and modulate the levels of inflammatory or anti-inflammatory cytokines that play a role in SLE.

systemic lupus erythematosusprobioticsgut microbiotaimmune tolerance
مقالوصول مفتوح20257استشهاد· Semantic Scholar

Dietary selenium nanoparticles ( SeNPs ) mediate intestinal microbiome and microbiota‐derived metabolites regulating the growth and immunity of Nile tilapia

Journal of the World Aquaculture Society · مجلد 56 (2)

Abstract Maintaining a healthy intestine is essential for growth and host defense mechanisms of farmed fish, particularly those densely stocked. In this context, maintaining a healthy intestinal microbiota for proper digestion, absorption, and integrity of the mucosa is of utmost importance. Nano‐form (SeNPs)‐enriched‐Pediastrum boryanum (Turpin) exhibits antimicrobial, antioxidant, and antitumor properties. Therefore, SeNPs are valuable nutritional supplements for farmed aquatic animals. Algogenic Se nanoparticles (SeNPs, 79.26 nm) were synthesized from the green microalga Pediastrum boryanum. A Nile tilapia (Oreochromis niloticus) basal diet was blended with 0.75 or 1.5 mg/kg dry feed of the SeNPs for and fed for 8 weeks. Comprehensive arrays of intestinal biomarker‐related parameters were investigated. Supplementation with SeNPs, particularly at a 1.5 mg/kg diet, improved growth performance, amylase and lipase activity, serotonin metabolite level, and intestinal morphometry. In addition, SeNPs supplementation suppressed serotonin levels. SeNPs at a 1.5 mg/kg diet were observed to be the optimal dose, as they showed better results concerning the increase in beneficial microbes and decrease in pathogenic microbes, demonstrating the potential role of SeNPs in growth improvement and enhanced intestinal functions. The sum of our data underscores the benefits of supplementing Nile tilapia feed with SeNPs to promote the growth and profitability of aquaculture.

selenium nanoparticlesOreochromis niloticusPediastrum boryanumgreen synthesis
مراجعةوصول مفتوح20256استشهاد· Semantic Scholar

Efficacy of Gut Microbiome-Targeted Therapies in Modulating Systemic Inflammation and Low-Grade Chronic Inflammatory States in Adults With Metabolic Disorders: A Systematic Review

Cureus · مجلد 17 (9) · e92881-e92881

Gut microbiome-targeted therapies have shown promise in promoting the outcomes of metabolic inflammation-related disease management. This review aims to assess the effectiveness of microbiome-targeted interventions and pinpoint the most promising therapies for clinical implementation. Following the PRISMA 2020 standards, we searched four main databases: PubMed, EMBASE, Scopus, and the Cochrane Library. We integrated medical subject headings (MeSH) and free-text keywords search pertinent to gut microbiome-targeted interventions, along with related outcomes such as inflammation and insulin resistance. English studies were conducted on primary adults with a metabolic disease diagnosis or deemed a high risk, and were mandated to report at least one outcome pertinent to metabolic health or systemic inflammation. To assess the risk bias, data were extracted, and the Cochrane Risk of Bias (RoB) 2.0 tool was employed. Fifteen studies fulfilled the inclusion criteria. A narrative synthesis was conducted. We found that probiotics significantly enhanced insulin resistance (HOMA-IR), reduced circulating endotoxin levels, decreased visceral fat, BMI, and fat mass, and increased beneficial taxa with obesity-associated bacteria reduction. However, inconsistent outcomes were shown for lipid parameters. Prebiotic therapies showed significant decreases in fasting glucose in overweight people, and insulin levels and HOMA-IR in patients with metabolic syndrome, enhanced anti-inflammatory effects (31% C-reactive protein (CRP) reduction, decreased interleukin (IL)-6, tumor necrosis factor-alpha (TNF)-α, and lipopolysaccharide (LPS) levels), and promoted butyrate-producing bacteria. Synbiotic interventions showed complementary benefits for glucose metabolism and body composition. Fecal microbiota transplantation (FMT) studies indicated improved insulin sensitivity and donor microbiota engraftment in responders. Fiber-rich diet trials markedly improved HbA1c levels in diabetic and prediabetic individuals. In conclusion, prebiotics demonstrated the most consistent metabolic and anti-inflammatory benefits across multiple parameters. Probiotics showed targeted effects on insulin resistance and body composition but inconsistent lipid outcomes. FMT and synbiotics require further investigation to establish clinical efficacy. This evidence supports prebiotics as a priority intervention for metabolic disease management through microbiome modulation.

systemic inflammationlow-grade inflammationmetabolic disordersprobiotics
مقالمفتوح (مستودع)20254استشهاد· Semantic Scholar

Precision Modulation of Gut Microbiome via Metagenomic-driven Dietary and Probiotic Interventions for Non-alcoholic Fatty Liver Disease Management in Obese Saudis

Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 596-601

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the causes of chronic liver diseases. Inconsistency in the microbiome population of individual guts and host–microbial interactions leads to low response in dietary and pharmacological-based treatments. This study aimed to develop and evaluate a metagenomic-guided, culturally adapted dietary and probiotic intervention to reduce hepatic fat and improve metabolic outcomes in obese Saudi adults with NAFLD. Materials and Methods: We combined gut metagenomic analysis, machine learning-based diet modelling and tailored probiotic supplementation to create an intervention platform. Probiotic specificity depends on functional deficits in bacteria participating in specific metabolic pathways, particularly bile acid metabolism. This technique supplements medication with microbiome-based drug processing. Results: At week 24, magnetic resonance imaging–proton density fat fraction (MRI-PDFF) decreased by −3.4 ± 2.2% (control), −8.9 ± 3.1% (diet) and −12.3 ± 3.8% (diet + probiotics); liver fat reduction was significant (analysis of variance (ANOVA) P = 0.0004). In the combined intervention, Faecalibacterium prausnitzii increased 2.3-fold (P = 0.003), faecal butyrate rose from 28.7 ± 4.1 to 45.2 ± 5.6 μmol/g (P = 0.002), faecal deoxycholic acid (fDCA) fell 34% (P = 0.010) with a rise in ursodeoxycholic acid (UDCA) (P = 0.015) and high-sensitivity C-reactive protein declined 42% (6.4 ± 1.7 to 3.7 ± 1.3 mg/L) versus 18% in controls (between-group P = 0.0008). Conclusion: Our precision-guided approach is a novel, scalable solution to managing NAFLD, leveraging the alignment of interactions between hosts, the microbiome and diet within a cultural context. The framework has the potential to optimise therapeutic response in high-risk Saudi communities, and the individual modulation of microbiomes on metabolic diseases is highlighted.

non-alcoholic fatty liver diseasegut microbiotaobesityprobiotic supplementation
مقالمفتوح (مستودع)20252استشهاد· Semantic Scholar

Predictive Immunonutrition for Paediatric Chronic Kidney Disease Surgery: A Multi-omic Data Fusion Framework through Canonical Correlation Analysis

Journal of Advanced Trends in Medical Research · مجلد 2 (1) · 69-75

Abstract Background: Preoperative immunonutrition is a promising approach to enhance surgical outcomes in high-risk populations, such as pediatric patients with chronic kidney disease (CKD). However, conventional protocols often fail to account for individual biological variability, limiting their effectiveness. Objectives: To develop a precision-based immunonutrition framework that integrates multi-omic data to predict individual responses and tailor nutritional interventions in pediatric CKD patients undergoing surgery. Methods: Our approach combines gut microbiome composition, host gene expression, and metabolic profiles using canonical correlation analysis (CCA) to extract latent multi-omic interactions. These features are then used to train a random forest classifier that predicts immunonutrition responsiveness with probabilistic scoring. The system dynamically adjusts interventions, including arginine and omega-3 fatty acid supplementation, based on predicted response levels. The framework leverages high-throughput sequencing, metabolomics, and scalable computing for real-time clinical integration. Results: The proposed system successfully predicted patient-specific responses to immunonutrition and supported personalized adjustments. It integrates smoothly with standard dietitian workflows and enhances clinical decision-making through data-driven insights. In pediatric CKD contexts, this approach demonstrated a marked potential for reducing post-operative complications. Conclusion: By shifting from a generalized to a precision-based paradigm, this framework lays the groundwork for individualized immunonutrition strategies in vulnerable pediatric populations. The model offers clinical scalability and may significantly improve surgical outcomes, particularly in personalized care settings like Saudi Arabia.

immunonutritionpediatric chronic kidney diseasepreoperative nutritional interventiongut microbiota
مراجعةمفتوح (مستودع)20251استشهاد· Semantic Scholar

The Gut-Scalp Axis: A Systematic Review of Dietary Interventions on Microbiome Dysbiosis in Scalp Disorders

Journal of Pioneering Medical Science · مجلد 14 (10) · 9-21

The goal of this systematic review was to measure the existing evidence for the efficacy of probiotics, prebiotics, synbiotics, postbiotics and dietary supplements in modifying gut and/or scalp microbiota in individuals with scalp disorders such as alopecia areata, androgenic alopecia and dandruff. Systematic searching across six databases- PubMed, Embase, Scopus, Web of Science, Cochrane CENTRAL and ClinicalTrials.gov was conducted to find human studies comparing interventions on the microbiome in clinically diagnosed scalp disorder patients. Randomized controlled trials, nonrandomized interventional designs and cross-sectional observational studies were deemed to be eligible study designs. Throughout the 14 studies, signals converged on a 4-24-week treatment window wherein clinically apparent improvements also accrued on hair and scalp endpoints. The trials also measured change and established statistically significant advantages-higher hair counts/density or lower dandruff severity-with p-values ranging <0.05-<0.0001, usually assessed by standardized trichoscopy/phototrichogram scoring and validated dandruff indices. Biomarker readouts also correlative with these clinical effects: multiple studies reported decreases in inflammatory mediators (e.g., IL-6, IL-31, TGF-β1, hsCRP) and shifts of antioxidant defenses upwards (e.g., SOD, with concurrent immunomodulatory effects such as increased IFN-γ), consistent with reduction of scalp inflammation and oxidative stress. Microbiome profiling (qPCR/16S/ITS) also repeatedly indicated increased Lactobacillus spp., decreased Cutibacterium acnes and/or Malassezia and normalization of community balance, with one Mendelian-randomization analysis providing evidence of causality: Corynebacterium appeared protective (OR = 0.82) but Betaproteobacteria and Burkholderiales paralleled higher disease risk (ORs = 1.21 and 1.20). The findings suggest that nutritional and topical interventions that influence the microbiome may be associated with beneficial changes in scalp symptoms, microbiota and inflammatory features in scalp disorder patients. While the general safety profile was acceptable, heterogeneity of study design, outcome measures and microbial analysis diminished the strength of conclusions reached.

scalp microbiomescalp disordersalopecia areataandrogenetic alopecia
مراجعةوصول مفتوح202441استشهاد· Semantic Scholar

Bioactive injectable mucoadhesive thermosensitive natural polymeric hydrogels for oral bone and periodontal regeneration

Frontiers in Bioengineering and Biotechnology · مجلد 12 · 1384326-1384326

Periodontitis is an inflammation-related condition, caused by an infectious microbiome and host defense that causes damage to periodontium. The natural processes of the mouth, like saliva production and eating, significantly diminish therapeutic medication residency in the region of periodontal disease. Furthermore, the complexity and diversity of pathological mechanisms make successful periodontitis treatment challenging. As a result, developing enhanced local drug delivery technologies and logical therapy procedures provides the foundation for effective periodontitis treatment. Being biocompatible, biodegradable, and easily administered to the periodontal tissues, hydrogels have sparked substantial an intense curiosity in the discipline of periodontal therapy. The primary objective of hydrogel research has changed in recent years to intelligent thermosensitive hydrogels, that involve local adjustable sol-gel transformations and regulate medication release in reaction to temperature, we present a thorough introduction to the creation and efficient construction of new intelligent thermosensitive hydrogels for periodontal regeneration. We also address cutting-edge smart hydrogel treatment options based on periodontitis pathophysiology. Furthermore, the problems and prospective study objectives are reviewed, with a focus on establishing effective hydrogel delivery methods and prospective clinical applications.

periodontitisperiodontal regenerationthermosensitive hydrogelmucoadhesive hydrogels
مراجعةوصول مفتوح202411استشهاد· Semantic Scholar

Shaping the future of gastrointestinal cancers through metabolic interactions with host gut microbiota

Heliyon · مجلد 10 (15) · e35336-e35336

Gastrointestinal (GI) cancers represent a significant global health challenge, driving relentless efforts to identify innovative diagnostic and therapeutic approaches. Recent strides in microbiome research have unveiled a previously underestimated dimension of cancer progression that revolves around the intricate metabolic interplay between GI cancers and the host's gut microbiota. This review aims to provide a comprehensive overview of these emerging metabolic interactions and their potential to catalyze a paradigm shift in precision diagnosis and therapeutic breakthroughs in GI cancers. The article underscores the groundbreaking impact of microbiome research on oncology by delving into the symbiotic connection between host metabolism and the gut microbiota. It offers valuable insights into tailoring treatment strategies to individual patients, thus moving beyond the traditional one-size-fits-all approach. This review also sheds light on novel diagnostic methodologies that could transform the early detection of GI cancers, potentially leading to more favorable patient outcomes. In conclusion, exploring the metabolic interactions between host gut microbiota and GI cancers showcases a promising frontier in the ongoing battle against these formidable diseases. By comprehending and harnessing the microbiome's influence, the future of precision diagnosis and therapeutic innovation for GI cancers appears more optimistic, opening doors to tailored treatments and enhanced diagnostic precision.

gastrointestinal cancergut microbiotahost-microbe metabolic interactionscancer metabolism
مراجعةوصول مفتوح2022134استشهاد· Semantic Scholar

Topical Probiotics: More Than a Skin Deep

Pharmaceutics · مجلد 14 (3) · 557-557

Skin, an exterior interface of the human body is home to commensal microbiota and also acts a physical barrier that protects from invasion of foreign pathogenic microorganisms. In recent years, interest has significantly expanded beyond the gut microbiome to include the skin microbiome and its influence in managing several skin disorders. Probiotics play a major role in maintaining human health and disease prevention. Topical probiotics have demonstrated beneficial effects for the treatment of certain inflammatory skin diseases such as acne, rosacea, psoriasis etc., and also found to have a promising role in wound healing. In this review, we discuss recent insights into applications of topical probiotics and their influence on health and diseases of the skin. Patents, commercially available topical probiotics, and novel probiotic impregnated fabrics have been emphasized. A thorough understanding of the relationship between probiotics and the skin microbiome is important for designing novel therapeutic approaches in using topical probiotics.

topical probioticsskin microbiomecommensal microbiotainflammatory skin diseases